Risk Prediction for Preeclampsia in CKD Patients: Development of a Model in a Retrospective Cohort

Overview

Journal J Nephrol

Publisher Springer

Specialty Nephrology

Date 2024 Jul 4

PMID 38965198

Authors

Fangchen Yuan

Zheng Li

Shi Chen

Yingdong He

Qian Chen

Jicheng Lv

Minghui Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Chronic kidney disease (CKD) may affect women of childbearing age and may lead to substantial maternal and foetal morbidity and mortality in pregnancy. There is a lack of prediction models for preeclampsia and adverse pregnancy outcomes in pregnant women with CKD. This study aimed to create a prediction nomogram for these issues.

Methods: This retrospective cohort study included clinical data from 627 women with CKD and their 627 pregnancies at Peking University First Hospital between January 1, 2009, and December 31, 2022. Multivariate logistic regression analysis was conducted to identify independent prognostic factors and develop a nomogram for predicting the occurrence of preeclampsia. The identified risk factors were utilised to construct the nomogram, which was subsequently internally validated using receiver operating characteristic (ROC) analysis and calibration curve assessment.

Results: According to our multivariate analysis, age, blood urea nitrogen (BUN), serum creatinine (Scr), mean arterial pressure (MAP), 24-h proteinuria, and CKD stage were identified as predictors of preeclampsia. Additionally, Scr, MAP, BUN, and 24-h proteinuria were found to be predictors of adverse pregnancy outcomes. The nomogram for predicting preeclampsia had an area under the ROC curve of 0.910, while the nomogram for predicting adverse pregnancy outcomes had an area under the ROC curve of 0.906. Both models demonstrated excellent discriminatory ability.

Conclusions: A nomogram based on 24-h proteinuria, serum creatinine, serum urea and age, and MAP allows predicting the occurrence of preeclampsia and other adverse pregnancy-related outcomes in CKD patients.

References

Piccoli G, Alrukhaimi M, Liu Z, Zakharova E, Levin A, World Kidney Day Steering Committee . What we do and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman's Day. Physiol Int. 2018; 105(1):1-18. DOI: 10.1556/2060.105.2018.1.6. View

Maria Maruotti G, Sarno L, Napolitano R, Mazzarelli L, Quaglia F, Capone A . Preeclampsia in women with chronic kidney disease. J Matern Fetal Neonatal Med. 2011; 25(8):1367-9. DOI: 10.3109/14767058.2011.634462. View

Reynolds M, Herrera C . Chronic Kidney Disease and Pregnancy. Adv Chronic Kidney Dis. 2020; 27(6):461-468. DOI: 10.1053/j.ackd.2020.04.003. View

LeFevre M . Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 161(11):819-26. DOI: 10.7326/M14-1884. View

Brown M, Magee L, Kenny L, Karumanchi S, McCarthy F, Saito S . Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018; 72(1):24-43. DOI: 10.1161/HYPERTENSIONAHA.117.10803. View

Webster K, Fishburn S, Maresh M, Findlay S, Chappell L . Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019; 366:l5119. DOI: 10.1136/bmj.l5119. View

Poon L, Shennan A, Hyett J, Kapur A, Hadar E, Divakar H . The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019; 145 Suppl 1:1-33. PMC: 6944283. DOI: 10.1002/ijgo.12802. View

Bramham K, Seed P, Lightstone L, Nelson-Piercy C, Gill C, Webster P . Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int. 2016; 89(4):874-85. DOI: 10.1016/j.kint.2015.10.012. View

Levey A, Stevens L . Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010; 55(4):622-7. PMC: 2846308. DOI: 10.1053/j.ajkd.2010.02.337. View

10.

Bramham K, Briley A, Seed P, Poston L, Shennan A, Chappell L . Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod Sci. 2011; 18(7):623-30. DOI: 10.1177/1933719110395403. View

11.

Piccoli G, Cabiddu G, Attini R, Vigotti F, Maxia S, Lepori N . Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol. 2015; 26(8):2011-22. PMC: 4520166. DOI: 10.1681/ASN.2014050459. View

12.

Zhang J, Ma X, Hao L, Liu L, Lv J, Zhang H . A Systematic Review and Meta-Analysis of Outcomes of Pregnancy in CKD and CKD Outcomes in Pregnancy. Clin J Am Soc Nephrol. 2015; 10(11):1964-78. PMC: 4633792. DOI: 10.2215/CJN.09250914. View

13.

Lambers Heerspink H, Brantsma A, de Zeeuw D, Bakker S, de Jong P, Gansevoort R . Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol. 2008; 168(8):897-905. DOI: 10.1093/aje/kwn209. View

14.

Kumakura S, Okamoto K, Takeuchi S, Yoshida M, Nakamichi T, Nagasawa T . Kidney function, blood pressure and proteinuria were associated with pregnancy outcomes of pregnant women with chronic kidney disease: a single-center, retrospective study in the Asian population. Clin Exp Nephrol. 2020; 24(6):547-556. DOI: 10.1007/s10157-020-01865-0. View

15.

Sorohan B, Andronesi A, Ismail G, Jurubita R, Obrisca B, Baston C . Clinical Predictors of Preeclampsia in Pregnant Women with Chronic Kidney Disease. Medicina (Kaunas). 2020; 56(5). PMC: 7279325. DOI: 10.3390/medicina56050213. View

16.

Wang M, Chen S, He Y, Zhao M, Yang H, Chen Q . Low-dose aspirin for the prevention of severe preeclampsia in patients with chronic kidney disease: a retrospective study : This is the study for kidney and pregnancy. J Nephrol. 2021; 34(5):1631-1639. DOI: 10.1007/s40620-021-01049-3. View